Toronto Dominion Bank
HELP

Toronto Dominion Bank’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Toronto Dominion Bank’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-47
Closed -$730 – 1457
2023
Q4 		$730 Buy
47
+12
+34% +$223 ﹤0.01% 1339
2023
Q3 		$707 Hold
35
– – ﹤0.01% 1461
2023
Q2 		$0 Hold
35
– – ﹤0.01% 1548
2023
Q1 		$1K Sell
35
-70
-67% -$1.14K ﹤0.01% 1363
2022
Q4 		$1K Buy
105
+66
+169% +$1.09K ﹤0.01% 1459
2022
Q3 		$1K Sell
39
-107
-73% -$2.9K ﹤0.01% 1517
2022
Q2 		$3K Sell
146
-39
-21% -$945 ﹤0.01% 1219
2022
Q1 		$6K Buy
185
+184
+18,400% +$6.72K ﹤0.01% 1282
2021
Q4 		$0 Hold
1
– – ﹤0.01% 1596
2021
Q3 		$0 Buy
+1
New +$88 ﹤0.01% 1394

Other funds holding HELP

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Toronto Dominion Bank's HELP Position: Q1 2024 in Review

Toronto Dominion Bank sold out of Helus Pharma Inc. Common Stock (HELP) in Q1 2024, closing a stake of 47 shares — an estimated $730 sold.

Toronto Dominion Bank first reported a position in HELP in Q3 2021 and held it in 10 quarters. The position peaked at $6K in Q1 2022. 107 funds tracked by Wall St. Rank hold HELP as of Q1 2024.

  • Toronto Dominion Bank reported no remaining Helus Pharma Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Toronto Dominion Bank sold 47 Helus Pharma Inc. Common Stock shares in Q1 2024, an estimated $730.
  • Toronto Dominion Bank first reported a position in Helus Pharma Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Toronto Dominion Bank's Helus Pharma Inc. Common Stock position peaked at $6K in Q1 2022.
  • 107 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q1 2024.

Based on Toronto Dominion Bank's 13F filing for Q1 2024, filed 14 May 2024.